Pfizer’s RSV vaccine Abrysvo is expected to generate global sales of $2.6bn in 2030. Credit: Art_Photo / Shutterstock.com Pfizer has announced positive topline results from
Researchers at the non-profit n-Lorem discovered and developed a personalised ASO therapy to treat a rare neurological disease. Credit: SurfsUp via Shutterstock. A patient with
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in your inbox. It’s Brittany subbing for Theresa this fine Monday.
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of phone
The FDA’s pilot programme is set to accelerate the development of novel drug and biological products for rare diseases. Credit: Tada Images via Shutterstock. US-based
Numinus Wellness Inc. (TSX:NUMI), a mental health care specializing in innovative treatments, recently commented on the FDA’s decision regarding Lykos Therapeutics’ new drug application for
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. A hard weekend
In June, the FDA’s Psychopharmacologic Drugs Advisory Committee issued a negative opinion of Lykos’ MDMA therapy. Image Credit: chase4concept / Shutterstock. Lykos Therapeutics’ midomafetamine (MDMA)
Researchers assessed whether dendritic spine head diameter in the temporal cortex is a better predictor of episodic memory performance in older adults than synapse quantity,
Researchers from the University of California, Berkeley, used the nematode model Caenorhabditis elegans to determine whether the olfactory nervous system could non-autonomously control the mitochondrial